Neeraj Deewan of Quantum Securities is of the view that one may prefer Sun Pharma for long term.
Neeraj Deewan of Quantum Securities told CNBC-TV18, "In pharma the correction is also going to be vicious when you see this kind of upmove. So after such a run up, one needs to be very careful. There will be still certain pockets, certain stocks like Sun Pharmaceutical Industries which is a largecap stock and which has good potential with the Ranbaxy Laboratories merger also happening. So, if you are in that kind of a stock, even if you buy today and you have a long-term perspective I do not think you will be loser in the longer term."
"There will be other stocks also which might be moving with the rally. So, one needs to be very specific and be picking the right stock even after it has run up so much," he said.
Anda sedang membaca artikel tentang
Prefer Sun Pharma for long term: Neeraj Dewan
Dengan url
https://untukkesehatanda.blogspot.com/2015/03/prefer-sun-pharma-for-long-term-neeraj.html?m=0
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Prefer Sun Pharma for long term: Neeraj Dewan
namun jangan lupa untuk meletakkan link
Prefer Sun Pharma for long term: Neeraj Dewan
sebagai sumbernya
0 komentar:
Posting Komentar